Table 2 Drug release study of Methotrexate (MTX) from B1, S1, and S3 composite beads.

From: An In Vitro Study of the Effects of Methotrexate Loaded Biocomposite Beads on MG63 Osteoblast Cells

Samples ID

ug/ml

Toxicity %

Viability %

 ± SD

P- value

IC50 ± SD

B1

1000

96.60

3.39

0.29

7.40E-10

306.99 ± 2.72

500

88.80

11.20

0.96

6.72E-09

250

50.08

49.91

1.47

4.78E-07

125

0.04

99.95

3.78

0.37

62.5

0

100

0.97

0.45

31.25

0

100

1.67

0.41

S1

1000

96.43

3.57

0.28

2.08E-09

204.74 ± 4.55

500

89.95

10.05

0.15

8.04E-10

250

65.39

34.61

1.32

4.41E-08

125

23.15

76.85

0.72

8.60E-10

62.5

0.70

99.29

0.81

0.03

31.25

0.13

99.87

0.91

0.33

S3

1000

96.38

3.61

0.098

1.11E-09

116.16 ± 1.57

500

90.78

9.21

0.67

5.92E-09

250

82.23

17.77

0.94

2.51E-08

125

56.74

43.25

0.81

2.69E-11

62.5

4.19

95.81

1.28

0.004

31.25

0.04

99.95

1.24

0.44